Daniel Desimone, MD
Internal Medicine · Crestwood, ILNPI 1447246822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. 2022 is the largest year on record at $406, 7.3 times the $55 reported in 2019.
Across 65 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$138
- AstraZeneca$106
- Lilly USA, LLC$105
- AbbVie$93
- Amarin Pharma, Inc.$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$69
- plus $466 from 14 others
What the payments were for
- Food & beverage$1,054100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $138 |
| AstraZeneca | 8 | $106 |
| Lilly USA, LLC | 6 | $105 |
| AbbVie(2 entities) | 4 | $93 |
| Amarin Pharma, Inc. | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Johnson & Johnson | 3 | $68 |
| Pfizer | 4 | $66 |
| Novartis | 4 | $55 |
| Eisai Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 3 | $37 |
| Bayer | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| GSK | 2 | $30 |
| Medtronic | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Amgen | 1 | $19 |
| Vivus LLC | 1 | $19 |
| Abbott | 1 | $14 |
How this compares
$1,054 in reported general payments places this provider in the 75th percentile of 5,182 internal medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Crestwood
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.